Journal of the International AIDS Society

Article	Citations
HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual	108
Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review	65
“If they had a place to live, they would be taking medication”: a qualitative study identifying strategies for engaging street‐connected young people in the HIV prevention‐care continuum in Ken	64
Counselling behavioural interventions for HIV, STI and viral hepatitis among key populations: a systematic review of effectiveness, values and preferences, and cost studies	59
When and how to intervene to improve the health of children born HIV‐free	59
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study	57
Sustaining the HIV/AIDS response: PEPFAR's vision	48
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limit	47
Understanding adaptive responses in PrEP service delivery in Belgian HIV clinics: a multiple case study using an implementation science framework	46
Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open‐label pharm	45
The effect of tracer contact on return to care among adult, “lost to follow‐up” patients living with HIV in Zambia: an instrumental variable analysis	43
Do not forget the children: a model‐based analysis on the potential impact of COVID‐19‐associated interruptions in paediatric HIV prevention and care	41
Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)	39
Contents	37
	37
	36
	36
India's adaptation of HIV services to ensure continuity of service delivery during the COVID‐19 pandemic	35
Issue Information	34
Differentiating the incidence and burden of HIV by age among women who sell sex: a systematic review and meta‐analysis	34
Patterns of person‐centred communications in public HIV clinics: a latent class analysis using the Roter interaction analysis system	33
Using community conversations to integrate violence screening and referrals into HIV care for young women living with HIV in Lusaka, Zambia	32
Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster‐randomized	32
Managers’ and providers’ perspectives on barriers and facilitators for the implementation of differentiated service delivery models for HIV treatment in Mozambique: a qualitative study	31
Community‐led monitoring: a voice for key populations in Zimbabwe	31

Issue Information	31
A cross‐sectional assessment of injection of “salts” and HIV transmission‐related behaviours among a cohort of people who inject drugs in Kyrgyzstan	30
Leveraging HIV self‐testing to achieve the UNAIDS 2025 targets in the South and Southeast Asia region	30
Experiences of oral pre‐exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study	30
Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics	28
Effectiveness of HIV self‐testing when offered within assisted partner services in Western Kenya (APS‐HIVST Study): a cluster randomized controlled trial	28
The lavender purge	28
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers	28
A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females	27
How community ART delivery may improve HIV treatment outcomes: Qualitative inquiry into mechanisms of effect in a randomized trial of community‐based ART initiation, monitoring and re‐supply (DO ART)	27
Preferences for transitional HIV care among people living with HIV recently released from prison in Zambia: a discrete choice experiment	27
Issue Information	26
Ageing with HIV: a longitudinal study of markers of resilience in young adults with perinatal exposure to HIV, with or without perinatally acquired HIV	26
Socio‐economic status and adherence to HIV preventive and therapeutic interventions: exploring the mediating role of food insecurity among men who have sex with men and transgender and non‐binary pers	26
Implementation strategies to improve HIV care cascade outcomes in low‐ and middle‐income countries: a systematic review from 2014 to 2021	25
Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community‐based sociometric network cohort in New Delhi, India	25
	25
Using FRAME to characterize provider‐identified adaptations to a stepped care intervention for adolescents and youth living with HIV in Kenya: a mixed methods approach	25
	25
Healthcare provisions associated with multiple HIV‐related outcomes among adolescent girls and young women living with HIV in South Africa: a cross‐sectional study	24
ChemsexPH: The association between chemsex, HIV status and adherence to antiretroviral therapy among men who have sex with men in the Philippines	24
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis	24
Feasibility and acceptability of peer‐delivered HIV and syphilis self‐test kits and assisted partner notification services for gay, bisexual and other men who have sex with men: a qualitative study in	24
Monitoring adherence to antiretroviral therapy among adolescents in Southern Uganda: comparing Wisepill to Self‐report in predicting viral suppression in a cluster‐randomized trial	24
Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania	23
Achieving equity for children and adolescents with perinatal HIV exposure: an urgent need for a paradigm shift	23
Adaptation and psychometric evaluation of a scale to measure oral pre‐exposure prophylaxis‐related stigma among key and vulnerable populations in Kenya	23
Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies	23
Sarcopenia in people living with HIV in Hong Kong: which definition correlates with health outcomes?	23
Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition	22
	21
Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta‐analysis	21
Improving PrEP access for adolescent girls and young women: a descriptive analysis of community‐based PrEP delivery in the DREAMS programme in Zambia	20
	20
Preferences for TB treatment and support delivery models among people living with TB in Eastern Cape, South Africa: a discrete choice experiment	20
COVID‐19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa	20
Feasibility and acceptability of persons on long‐acting cabotegravir for HIV prevention in the SEARCH Dynamic Choice HIV Prevention trial extension in rural Kenya and Uganda: a longitudinal cohort stu	20
Cost‐Effectiveness and Budget Impact Analysis of the Implementation of Differentiated Service Delivery Models for HIV Treatment in Mozambique: a Modelling Study	19
Lessons learned from community engagement regarding phylodynamic research with molecular HIV surveillance data	19
Client experiences with “Dynamic Choice Prevention,” a model for flexible patient‐centred HIV prevention delivery in rural Eastern Africa	19
Impart: findings from a prison‐based model of HIV assisted partner notification in Indonesia	19
Issue Information	19
Issue Information	18
Silver linings: how COVID‐19 expedited differentiated service delivery for HIV	18
Methodological issues in the designing and reporting of frequentist and Bayesian meta‐analysis to assess COVID‐19 outcomes among PLHIV with various comorbidities	18
Providing differentiated service delivery to the ageing population of people living with HIV	18
“It gives me the strength and courage to take care of myself”: a qualitative exploration of experiences with STI testing among women who initiated PrEP during pregnancy in Western Kenya	18
A one‐stop shop model for improved efficiency of pre‐exposure prophylaxis delivery in public clinics in western Kenya: a mixed methods implementation science study	18
Uncovering ART adherence inconsistencies: An assessment of sustained adherence among adolescents in South Africa	18
The wisdom of mistrust: qualitative insights from transgender women who participated in PrEP research in Lima, Peru	18

Ethical HIV research with transgender and non‐binary communities in the United States	18
Certification of lay providers to deliver key population‐led HIV services in Thailand's National Healthcare System: lessons learned	18
Impact of the COVID‐19 pandemic on TB services at ART programmes in low‐ and middle‐income countries: a multi‐cohort survey	17
AUTHOR INDEX	17
The impact of prevention‐effective PrEP use on HIV incidence: a mathematical modelling study	17
Factors associated with mobile app‐based ordering of HIV self‐test kits among men who have sex with men in Atlanta, Detroit and New York City: an exploratory secondary analysis of a randomized control	17
Caring for the whole person: transgender‐competent HIV pre‐exposure prophylaxis as part of integrated primary healthcare services in Vietnam	17
Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo birth outcomes surveillance study	17
HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross‐sectional study in the Democratic Republic of Congo	16
What can we learn from HIV, COVID‐19 and mpox stigma to guide stigma‐informed pandemic preparedness?	16
	16
Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID‐19 pandemic in China: a qualitative study	16
HIV knowledge and access to testing for people with and without disabilities in low‐ and middle‐income countries: evidence from 37 Multiple Indicator Cluster Surveys	16
Clients in Uganda accessing preferred differentiated antiretroviral therapy models achieve higher viral suppression and are less likely to miss appointments: a cross‐sectional analysis	16
Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual	16
HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial	16
Community contexts and knowledge: accountability, leadership and meaningful involvement of communities in Programme Science	16
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study	16
Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP	16
A thank you note to our peer reviewers (2024)	15
Experiences, perceptions and potential impact of community‐based mentor mothers supporting pregnant and postpartum women with HIV in Kenya: a mixed‐methods study	15
	15
Fostering citizen‐engaged HIV implementation science	15
Use of quality‐of‐life instruments for people living with HIV: a global systematic review and meta‐analysis	15
Lessons from the field: understanding the use of a youth tailored U = U tool by peer educators in Lesotho with adolescents and youth living with HIV	15
A prospective cohort study of the SEARCH integrated HIV/hypertension community health worker‐led intervention in rural Kenya and Uganda	15
Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in France	15
Shaping and coordinating the implementation science agenda for injectable cabotegravir for PrEP: the role of the Biomedical Prevention Implementation Collaborative (BioPIC)	15
Improving access to integrated community‐based HIV, HCV and harm reduction services for people who inject drugs in Putao district, North Myanmar	15
Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United States	15
	15
High acceptability, feasibility and sustainability of a direct‐to‐pharmacy differentiated PrEP delivery model in public health HIV clinics in Kenya: perspectives of PrEP clients and healthcare provide	15
Finally, PrEP choices! But will clients ever have a choice?	15
Assessing the HIV care continuum among transgender women during 11 years of follow‐up: results from the Netherlands’ ATHENA observational cohort	15
Evidence from high‐income countries on the effectiveness of psychosocial interventions to improve mental health, wellbeing and quality of life for adults living with HIV: a systematic review and meta‐	15
The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV‐exposed but uninfected: a prospective study in the United States	15
South African healthcare workers’ knowledge of dolutegravir's drug–drug interactions in the first year of its rollout: a cross‐sectional online survey	14
Advanced disease programming brings much needed attention and improvements to inpatient paediatric HIV care in Mozambique	14
Issue Information	14
Examining barriers to antiretroviral therapy initiation in infants living with HIV in sub‐Saharan Africa despite the availability of point‐of‐care diagnostic testing: a narrative systematic review	14
Sex modifies the association between HIV and coronary artery disease among older adults in Uganda	14
Ensuring impact of long‐acting HIV therapeutics through multi‐level treatment research: a view from NIH	14
Characterizing adolescent and youth‐friendly HIV services: a cross‐sectional assessment across 16 global sites	14
Issue Information	14
Implementation and resource needs for long‐acting PrEP in low‐ and middle‐income countries: a scoping review	14
Implementation research and the HIV response: Taking stock and charting the way forward	14
REPRIEVE final results: What does it mean for guidelines in low‐ and middle‐income countries?	14
To effectively reduce violence against women living with HIV, we must make healthcare systems places of safety	13
Issue Information	13
	13
Preferences for models of sexual health service delivery among gay, bisexual and other men who have sex with men in Australia: a discrete choice experiment	13
Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent	13
Health‐related needs reported by adolescents living with HIV and receiving antiretroviral therapy in sub‐Saharan Africa: a systematic literature review	13
Awareness and intention to use event‐driven and long‐acting injectable pre‐exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross‐sectional	13
	13
Association between HIV PrEP indications and use in a national sexual network study of US men who have sex with men	13
Weight gain during the dolutegravir transition in the African Cohort Study	13
Aligning HIV treatment and hypertension clinic visits and dispensing as a first step towards service delivery integration in South Africa	13
Providing HIV‐assisted partner services to partners of partners in western Kenya: an implementation science study	12
Differences in clinical characteristics between adolescents and young adults with perinatally and sexually acquired HIV in the Asia‐Pacific region	12
Prevalence of cardiovascular risk factors by HIV status in a population‐based cohort in South Central Uganda: a cross‐sectional survey	12
The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub‐Saharan Africa: a scoping review	12
Being yourself is a defect: analysis of documented rights violations related to sexual orientation, gender identity and HIV in 2022 using the REAct system in six eastern European, Caucasus and Central	12
Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort	12
Improving ART initiation among men who use HIV self‐testing in Malawi: a qualitative study	12
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study	12
HIV pre‐exposure prophylaxis programme preferences among sexually active HIV‐negative transgender and gender diverse adults in the United States: a conjoint analysis	12
Prevalence and co‐occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low‐ and middle‐income countries: a cross‐sectional study	12
Non‐clinical considerations for supporting accelerated inclusion of pregnant women in pre‐licensure clinical trials with anti‐HIV agents	12
The ethics of exclusion: why pregnant and lactating women must be front and centre of HIV research	12
	11
Abstract Supplement Abstracts from IAS 2023, the 12th IAS Conference on HIV Science, 23 – 26 July, Brisbane, Australia & Virtual	11
PrEP awareness and protective barrier negotiation among transgender people attracted to men in Aotearoa New Zealand	11
Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review	11
The impact of COVID‐19 on multi‐month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR‐supported countries: a multi‐country analysis	11
Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population‐based survey data	11
	11
Psychosocial interventions for improving engagement in care and health and behavioural outcomes for adolescents and young people living with HIV: a systematic review and meta‐analysis	11
Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies	11
An evaluation of nine culturally tailored interventions designed to enhance engagement in HIV care among transgender women of colour in the United States	11

Failing to learn the lessons: the U.S. response on global health security ignores 20 years of PEPFAR	11
Acceptability and satisfaction towards self‐collection for chlamydia and gonorrhoea testing among transgender women in Tangerine Clinic, Thailand: shifting towards the new normal	11
AUTHOR INDEX	11
	11
Seizing the moment: the potential of PrEP choice and innovation to transform HIV prevention	11
Occupational post‐exposure prophylaxis among healthcare workers: a scoping review of factors affecting optimal utilization	11
Person‐centred, integrated non‐communicable disease and HIV decentralized drug distribution in Eswatini and South Africa: outcomes and challenges	11
Treatment‐naïve people living with HIV aged 50 years or older in Beijing, China, 2010–2020: joinpoint regression model analysis of surveillance data	11
Estimating male circumcision coverage in 15 priority countries in sub‐Saharan Africa	11
Knowledge as resistance: advancing global health in challenging times	10
Long‐acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI U	10
“People have options”: a qualitative study of experiences and influences of PrEP choice among women in South Africa	10
The power of one – in memoriam of Paul E. Farmer	10
“It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid‐19	10
A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN‐035	10
	10
Issue Information	10
Retention in care and viral suppression after same‐day ART initiation: One‐year outcomes of the SLATE I and II individually randomized clinical trials in South Africa	10
Population‐level effectiveness of pre‐exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data	10
AUTHOR INDEX	10
	10
Including transgender populations in mathematical models for HIV treatment and prevention: current barriers and policy implications	10
	10
The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study	10
Oral pre‐exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study	10
Global HIV mortality trends among children on antiretroviral treatment corrected for under‐reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaborati	10
Bringing together the pieces: the need for holistic care for women with HIV	10
	10
A citizen science approach to develop a digital intervention to reduce HIV stigma and promote HIV self‐testing among adolescents and young adults: a mixed methods analysis from Kazakhstan	9
Comorbidities and HIV‐related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low‐ and middle‐income countries: a cross‐sectional study	9
PrEP preferences and early acceptability of injectable cabotegravir among pregnant and lactating people in Cape Town, South Africa: findings from the PrEPared to Choose study	9
Recognizing and disrupting stigma in implementation of HIV prevention and care: a call to research and action	9
HIV prevention programme with young women who sell sex in Mombasa, Kenya: learnings for scale‐up	9
Programme science methodologies and practices that address “FURRIE” challenges: examples from the field	9
Untapped potential of post‐exposure prophylaxis in sub‐Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia	9
Projection of age of individuals living with HIV and time since ART initiation in 2030: estimates for France	9
Transforming PrEP marketing: understanding the place of PrEP in the hearts and minds of adolescent girls and young women in sub‐Saharan Africa	9
Issue Information	9
Characteristics of individuals who received post‐exposure prophylaxis and HIV seroconversion in Malawi: an analysis of national routine HIV testing data	9
Addressing stigma and discrimination at scale: uniting for a common vision while acknowledging local realities	9
Pre‐exposure prophylaxis in real life: experience from a prospective, observational and demonstration project among men who have sex with men in Benin, West Africa	9
Non‐communicable disease (NCD) risk among people living with HIV in KwaZulu‐Natal, South Africa: evidence from a randomised trial of community‐based differentiated service delivery	9
Beating the odds: medicines alone will not stop HIV	8
Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study	8
	8
Predictors of PrEP awareness, PrEP discussion and interest in long‐acting injectable PrEP among Filipina transfeminine adults	8
Sustaining HIV service delivery to key population clients using client‐centered models during the debate and enactment of the Anti‐Homosexuality Act in Uganda	8
AUTHOR INDEX	8
Modelling the impact of CD4 testing on mortality from TB and cryptococcal meningitis among patients with advanced HIV disease in nine countries	8
Differentiated service delivery for people using second‐line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu‐Natal, South Africa	8
	8
Community‐based differentiated service delivery models incorporating multi‐month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits:	8
Correction to Evaluation of point‐of‐care diagnostics for sexually transmitted infection on oral PrEP initiation and persistence among young people in South Africa: a randomized controlled study	8
Distribution of antiretroviral therapy through private pharmacies and postal courier services during COVID‐19 in Botswana: acceptability and reach of two out‐of‐facility individual differentiated serv	8
AUTHOR INDEX	8
Persistent low‐level viraemia is associated with non‐infectious comorbidities in an observational cohort in four African countries	8
Adults with perinatally acquired HIV in low‐ and middle‐income settings: time for a generational shift in HIV care and global guidance	8
How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub‐Saharan Africa: a mixed methods analysis	8
Very high HIV prevalence and incidence among men who have sex with men and transgender women in Indonesia: a retrospective observational cohort study in Bali and Jakarta, 2017–2020	8
HIV vaccines in 2022: where to from here?	8
Issue Information	8
	8
Condomless receptive anal intercourse is associated with markers of mucosal inflammation in a cohort of men who have sex with men in Atlanta, Georgia	8
Characterizing HIV seroconversions among a cohort of oral PrEP users in South Africa	8
The science at HIVR4P 2024: The era of choice in biomedical HIV prevention	8
	8
New tricks for an old dog: opportunities for better tuberculosis control	8
On the risk of using raw regional data on new HIV infections in France	8
Prevalence, correlates and solutions to people with HIV in China being refused treatment for diseases not related to HIV: a mixed‐methods study	8
Excess mortality attributable to AIDS among people living with HIV in high‐income countries: a systematic review and meta‐analysis	8
Impact of SMS and peer navigation on retention in HIV care among adults in South Africa: results of a three‐arm cluster randomized controlled trial	8
Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey	8
HIV awareness and prevention strategies among transgender women in the Eastern and Southern United States: findings from the LITE Study	8
Issue Information	8